CD8A and neoplasm: Furthermore, it has been demonstrated that increasing CD8+ T cell antitumour responses using a chimeric antigen receptor (CAR) T-cell specific for FAPα can suppress the growth of a variety of subcutaneously implanted tumours in mice [292].